Steve Vergamini

Director, US Market Access Marketing And Strategy (oncology Portfolio) at Daiichi Sankyo

Steve Vergamini is an accomplished professional with extensive experience in oncology marketing and strategic leadership. Currently serving as the Director of US Market Access Marketing and Strategy for the Oncology Portfolio at Daiichi Sankyo, Inc. since September 2019, Steve previously held various roles including Associate Director for US Oncology Marketing and National Business Manager for gastric oncology at the same company. Prior experience includes senior management positions at Clovis Oncology and Janssen Pharmaceuticals, along with foundational roles at Genentech. Before entering the pharmaceutical industry, Steve served in the US Army for 15 years, achieving high-ranking positions such as Battalion Operations Officer and Special Operations Battle Captain. Steve holds multiple advanced degrees, including an MBA from Cornell Johnson Graduate School of Management and an additional MBA from Smith School of Business at Queen's University, complemented by attendance at Northwestern University's Kellogg School of Management.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Daiichi Sankyo

21 followers

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.


Industries

Headquarters

Tokyo, Japan

Employees

1,001-5,000

Links